New 17β-estradiol (E2) derivatives 1−11 were synthesized from an estrone derivative by addition of organometallic reagents prepared from protected α,ω-alkynols and further elaboration of the addition products. The estrogenic activity of these novel compounds was determined using in vitro binding competition assay and transactivation analysis. Among the E2 derivatives synthesized, compound 2 showed the highest transactivation potency and was therefore tested for its ability to modulate cutaneous wound healing in vivo. Compound 2’s ability to accelerate wound healing in ovariectomized mice and decrease the production of inflammatory molecules was comparable to that of E2. However, the activity of compound 2 was not superimposable to E2 with regard to the cells involved in the wound repairing process. When locally administered, compound 2 did not show any systemic activity on ER. This class of compounds with clear beneficial effects on wound healing and suitable for topical administration may lead to the generation of innovative drugs for an area of unmet clinical need

Novel Locally Active Estrogens Accelerate Cutaneous Wound Healing. A Preliminary Study / M. Brufani, F. Ceccacci, L. Filocamo, B. Garofalo, R. Joudioux, A. La Bella, F. Leonelli, L.M. Migneco, R. Marini Bettolo, P.M. Farina, G.S. Ashcroft, C. Routley, M. Hardman, C. Meda, G. Rando, A. Maggi. - In: MOLECULAR PHARMACEUTICS. - ISSN 1543-8384. - 6:2(2009 Mar), pp. 543-556. [10.1021/mp800206b]

Novel Locally Active Estrogens Accelerate Cutaneous Wound Healing. A Preliminary Study

C. Meda;G. Rando
Penultimo
;
A. Maggi
Ultimo
2009

Abstract

New 17β-estradiol (E2) derivatives 1−11 were synthesized from an estrone derivative by addition of organometallic reagents prepared from protected α,ω-alkynols and further elaboration of the addition products. The estrogenic activity of these novel compounds was determined using in vitro binding competition assay and transactivation analysis. Among the E2 derivatives synthesized, compound 2 showed the highest transactivation potency and was therefore tested for its ability to modulate cutaneous wound healing in vivo. Compound 2’s ability to accelerate wound healing in ovariectomized mice and decrease the production of inflammatory molecules was comparable to that of E2. However, the activity of compound 2 was not superimposable to E2 with regard to the cells involved in the wound repairing process. When locally administered, compound 2 did not show any systemic activity on ER. This class of compounds with clear beneficial effects on wound healing and suitable for topical administration may lead to the generation of innovative drugs for an area of unmet clinical need
Estrogen receptor; Locally active estrogens; Soft drugs; Wound healing
Settore BIO/14 - Farmacologia
mar-2009
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/69715
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 18
  • ???jsp.display-item.citation.isi??? 17
social impact